Many factors influence effective clearance. Changes in dialyzer surface
area exposure, reduced blood flow, inadequate dialysate flow, recirculation, and other complications can all lead to the under delivery of the prescribed hemodialysis dose.1 This feature
Uses conductivity sensors to meausre dialysate
sodium concentration pre and post dialyzer to
detemine effective dialyzer urea clearance
Measures and predicts adequacy goal
Alerts clinician if target Kt/V will not
be met
Facilitates early intervention during the
treatment to achieve adequate therapy
1Steur RR, et al. “Hematocrit as an Indicator of Blood Volume
 and a Predictor of Intradialytic Morbid Events.” ASAIO Journal
 M691-M696, 1994




Fresenius Logo

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling at

This site is intended for visitors from the United States.

© 2013-2017, Fresenius Medical Care, All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, bibag, DIASAFE, Fresenius Polysulfone, Twister, Crit-Line, CLiC, and Clinical Data eXchange (CDX) are trademarks of Fresenius Medical Care Holdings, Inc., or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies in the United States and is used under license from Advanced Renal Technologies. All other trademarks are the property of their respective owners. P/N 102054-01 Rev C 10/2017